1. Home
  2. CPRX vs WULF Comparison

CPRX vs WULF Comparison

Compare CPRX & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • WULF
  • Stock Information
  • Founded
  • CPRX 2002
  • WULF 1952
  • Country
  • CPRX United States
  • WULF United States
  • Employees
  • CPRX N/A
  • WULF N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • WULF EDP Services
  • Sector
  • CPRX Health Care
  • WULF Technology
  • Exchange
  • CPRX Nasdaq
  • WULF Nasdaq
  • Market Cap
  • CPRX 2.4B
  • WULF 1.6B
  • IPO Year
  • CPRX 2006
  • WULF 1995
  • Fundamental
  • Price
  • CPRX $21.15
  • WULF $5.06
  • Analyst Decision
  • CPRX Strong Buy
  • WULF Strong Buy
  • Analyst Count
  • CPRX 6
  • WULF 9
  • Target Price
  • CPRX $29.50
  • WULF $5.69
  • AVG Volume (30 Days)
  • CPRX 936.6K
  • WULF 20.0M
  • Earning Date
  • CPRX 11-06-2024
  • WULF 11-12-2024
  • Dividend Yield
  • CPRX N/A
  • WULF N/A
  • EPS Growth
  • CPRX N/A
  • WULF N/A
  • EPS
  • CPRX 0.58
  • WULF N/A
  • Revenue
  • CPRX $434,475,000.00
  • WULF $120,247,000.00
  • Revenue This Year
  • CPRX $21.33
  • WULF $129.08
  • Revenue Next Year
  • CPRX $17.29
  • WULF $87.70
  • P/E Ratio
  • CPRX $36.45
  • WULF N/A
  • Revenue Growth
  • CPRX 43.42
  • WULF 197.49
  • 52 Week Low
  • CPRX $11.89
  • WULF $0.89
  • 52 Week High
  • CPRX $21.85
  • WULF $6.51
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 64.52
  • WULF 61.45
  • Support Level
  • CPRX $19.54
  • WULF $3.76
  • Resistance Level
  • CPRX $21.85
  • WULF $5.23
  • Average True Range (ATR)
  • CPRX 0.49
  • WULF 0.37
  • MACD
  • CPRX 0.14
  • WULF 0.08
  • Stochastic Oscillator
  • CPRX 82.40
  • WULF 95.24

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: